Bayer Current Ratio 2006-2019 | BAYRY

Current and historical current ratio for Bayer (BAYRY) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bayer current ratio for the three months ending September 30, 2019 was 1.29.
Bayer Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $37.27B $28.98B 1.29
2019-06-30 $36.83B $28.54B 1.29
2019-03-31 $37.14B $27.14B 1.37
2018-12-31 $36.53B $26.95B 1.36
2018-09-30 $37.37B $23.48B 1.59
2018-06-30 $45.10B $31.92B 1.41
2018-03-31 $40.77B $16.10B 2.53
2017-12-31 $33.99B $15.36B 2.21
2017-09-30 $29.58B $19.60B 1.51
2017-06-30 $35.91B $20.63B 1.74
2017-03-31 $28.48B $18.57B 1.53
2016-12-31 $33.69B $20.51B 1.64
2016-09-30 $28.09B $18.61B 1.51
2016-06-30 $27.86B $19.27B 1.45
2016-03-31 $29.48B $19.23B 1.53
2015-12-31 $26.45B $18.86B 1.40
2015-09-30 $27.81B $21.52B 1.29
2015-06-30 $28.94B $22.97B 1.26
2015-03-31 $28.16B $22.87B 1.23
2014-12-31 $29.55B $20.61B 1.43
2014-09-30 $33.65B $19.58B 1.72
2014-06-30 $28.79B $20.12B 1.43
2014-03-31 $30.27B $20.95B 1.45
2013-12-31 $25.28B $18.63B 1.36
2013-09-30 $25.97B $19.54B 1.33
2013-06-30 $26.75B $19.42B 1.38
2013-03-31 $27.10B $18.19B 1.49
2012-12-31 $24.42B $16.85B 1.45
2012-09-30 $25.58B $17.19B 1.49
2012-06-30 $25.54B $17.21B 1.48
2012-03-31 $29.29B $18.54B 1.58
2011-12-31 $27.95B $18.65B 1.50
2011-09-30 $28.15B $18.71B 1.50
2011-06-30 $28.02B $19.09B 1.47
2011-03-31 $26.83B $15.33B 1.75
2010-12-31 $24.32B $14.39B 1.69
2010-09-30 $22.84B $13.13B 1.74
2010-06-30 $24.30B $15.09B 1.61
2010-03-31 $25.97B $15.41B 1.69
2009-12-31 $23.70B $12.51B 1.89
2009-09-30 $24.62B $13.14B 1.87
2009-06-30 $23.06B $12.93B 1.78
2009-03-31 $25.98B $18.32B 1.42
2008-12-31 $25.25B $20.36B 1.24
2008-09-30 $26.48B $22.18B 1.19
2008-06-30 $27.08B $22.95B 1.18
2008-03-31 $26.91B $16.61B 1.62
2007-12-31 $22.84B $14.55B 1.57
2007-09-30 $23.54B $14.26B 1.65
2007-06-30 $24.69B $15.42B 1.60
2007-03-31 $28.46B $18.32B 1.55
2006-12-31 $25.12B $19.49B 1.29
2006-09-30 $26.26B $20.46B 1.28
2006-06-30 $24.86B $25.41B 0.98
2006-03-31 $20.57B $9.65B 2.13
2005-12-31 $20.66B $11.30B 1.83
2005-09-30 $20.18B $10.38B 1.94
2005-06-30 $20.04B $10.98B 1.82
2005-03-31 $21.64B $13.00B 1.67
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $52.894B $48.230B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $339.589B 14.84
Roche Holding AG (RHHBY) Switzerland $279.418B 0.00
Merck (MRK) United States $187.177B 14.22
Novartis AG (NVS) Switzerland $185.475B 15.44
Pfizer (PFE) United States $176.138B 10.76
Novo Nordisk (NVO) Denmark $141.488B 24.29
Eli Lilly (LLY) United States $130.559B 22.59
Bristol-Myers Squibb (BMY) United States $123.757B 11.74
AstraZeneca (AZN) United Kingdom $114.895B 24.73
AbbVie (ABBV) United States $108.417B 8.21
Sanofi (SNY) France $107.453B 12.77
GlaxoSmithKline (GSK) United Kingdom $92.874B 11.78
H Lundbeck (HLUYY) Denmark $5.897B 10.25
Innoviva (INVA) United States $1.164B 8.03